Hang Lung (10 HK) Is Still Inexpensive. Lack Of Liquidity Not Helping
Back in January 2024, Hang Lung Properties (101 HK) (HLP) offered a scrip dividend option for FY23, a first for the company. Scrip dividends have been afforded ever since.
HLP’s major shareholder, Hang Lung (10 HK), has taken full advantage of this option, increasing its stake by 4%; and potentially up to 5% when factoring in FY25 dividends.
Interestingly, the implied stub has widened since the commencement of scrip dividends, with the market assigning HK$600mn less for the stub ops.
The Trade:
HLG is cheap (0.23x P/B), albeit illiquid.
Expect HLG to continue to exercise its rights to HLP scrip for the foreseeable future.
There may some grand plan afoot.
But I’d still be cautious jumping into either HLG or HLP in a major way.
This insight is labelled bullish, as I’m not bearish.
Keep reading with a 7-day free trial
Subscribe to Hong Kong/China M&A/Events to keep reading this post and get 7 days of free access to the full post archives.

